Philippos Koulousakis
Overview
Explore the profile of Philippos Koulousakis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopez A, Siddiqi F, Villeneuve J, Ureshino R, Jeon H, Koulousakis P, et al.
Nat Chem Biol
. 2024 Nov;
PMID: 39482469
Tauopathies are neurodegenerative diseases that manifest with intracellular accumulation and aggregation of tau protein. These include Pick's disease, progressive supranuclear palsy, corticobasal degeneration and argyrophilic grain disease, where tau is...
2.
Early Inhibition of Phosphodiesterase 4B (PDE4B) Instills Cognitive Resilience in APPswe/PS1dE9 Mice
Rombaut B, Schepers M, Tiane A, Mussen F, Koole L, Kessels S, et al.
Cells
. 2024 Jun;
13(12.
PMID: 38920631
Microglia activity can drive excessive synaptic loss during the prodromal phase of Alzheimer's disease (AD) and is associated with lowered cyclic adenosine monophosphate (cAMP) due to cAMP phosphodiesterase 4B (PDE4B)....
3.
Koulousakis P, Willems E, Schepers M, Rombaut B, Prickaerts J, Vanmierlo T, et al.
J Alzheimers Dis
. 2023 Nov;
96(3):1207-1219.
PMID: 37927260
Background: Current treatment options for Alzheimer's disease (AD) are limited, inefficient, and often have serious side effects. Oxytocin is a neuropeptide implicated in a variety of central processes, such as...
4.
Koulousakis P, Tiane A, Hellings N, Prickaerts J, van den Hove D, Vanmierlo T
Neural Regen Res
. 2022 Jul;
18(2):331-332.
PMID: 35900421
No abstract available.
5.
van den Hove D, Riemens R, Koulousakis P, Pishva E
Brain Pathol
. 2020 Jul;
30(5):978-983.
PMID: 32654262
Alzheimer's disease (AD) represents a devastating progressive neurodegenerative disease with a complex pathophysiology, affecting millions of people worldwide. Recent epigenome-wide association studies suggest a key role for epigenetic mechanisms in...
6.
Koulousakis P, van den Hove D, Visser-Vandewalle V, Sesia T
J Alzheimers Dis
. 2019 Dec;
73(2):461-466.
PMID: 31868670
Deep brain stimulation (DBS) of the nucleus basalis of Meynert (NBM) has been shown to exert promising therapeutical effects in a pilot study with patients suffering from Alzheimer's disease (AD)....
7.
Koulousakis P, Andrade P, Visser-Vandewalle V, Sesia T
J Alzheimers Dis
. 2019 May;
69(4):905-919.
PMID: 31104014
The nucleus basalis of Meynert (nbM) was first described at the end of the 19th century and named after its discoverer, Theodor Meynert. The nbM contains a large population of...